Megan Coylewright

Interventional cardiologist / Cardiologist
Essentia Health-St. Mary's Medical Center (Duluth, Building B) - Duluth, United States of America

Latest contributions

Innovative approaches to refractory heart failure: devices and therapies to the rescue

23 May 2025 – From EuroPCR 2025

This session highlights innovative device-based therapies for refractory heart failure, emphasizing the integration of neuromodulation, decongestive strategies, and the synergy with pharmacological treatments. Case presentations illustrate the evolving landscape of advanced heart failure management.

Innovative approaches to refractory heart failure: devices and therapies to the rescue

TAVI in women

22 May 2025 – From EuroPCR 2025

Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...

TAVI in women

Academic Research Consortium initiative on left atrial appendage closure – standardising definitions and endpoints to move forward

21 May 2025

Philippe Garot describes the EuroPCR 2025 session on left atrial appendage closure (LAAC), which offers a preview of the upcoming new consensus document developed by the Academic Research Consortium.

Dr Philippe Garot

Author

Philippe Garot

Academic Research Consortium on LAA closure

21 May 2025 – From EuroPCR 2025

Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.

Academic Research Consortium on LAA closure

Complex PCI in a TAVI patient - LIVE case

20 May 2025 – From EuroPCR 2025

An 84-year-old patient with a history of ischemic stroke in 2017, hypertension, diabetes, dyslipidemia, and a preserved LV function (63 %) presented with a severe symptomatic aortic stenosis. The coronary angiography revealed a severe and calcified stenosis of the distal left main.
Operators implanted an Edwards Sapien...

Complex PCI in a TAVI patient - LIVE case

How to improve TAVI durability - LIVE case

26 Nov 2024 – From PCR London Valves 2024

Explore two fascinating cases tackling severe aortic valve challenges with innovative approaches:

  • LIVE Case: An 84-year-old woman with a history of breast cancer and TAVI (Evolut Pro 29) in 2016, presenting with symptomatic severe TAVI stenosis. CT revealed a true ID of 19 mm. The team implanted...
TAVI durability and treatment options

Patient-driven strategies to improve women's experience of heart valve disease: better partnerships for better outcomes

25 Nov 2024 – From PCR London Valves 2024

Curious about how to improve care for women with heart valve disease?

Join this session to explore patient-centred strategies, gain insights from the latest SMART data and dive into the RHEIA trial. You’ll learn how to integrate shared decision-making and strengthen Heart Team partnerships to deliver better outcomes...

Patient-driven strategies to improve women's experience of heart valve disease: better partnerships for better outcomes

TAVI for pure aortic regurgitation - LIVE case

25 Nov 2024 – From PCR London Valves 2024

Watch a LIVE case followed by a recorded case on aortic regurgitation:

  • An 86-year-old male with a history of stroke and prostate cancer presenting acute heart failure due to severe pure aortic regurgitation and LV dysfunction (EF 39%). A 27 mm JenaValve Trilogy prosthesis was implanted without...
TAVI for pure aortic regurgitation

Patient-prosthesis mismatch: surgical and transcatheter approaches - LIVE case

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover different surgical and transcatheter approaches:

  • Part 1: Bioprosthesis aortic valve stenosis
    A 73-year-old male, with diabetes, BMI 29, atrial fibrillation, history of SAVR 15 years ago (Perimount 27) presents a symptomatic severe surgical valve stenosis with a preserved LV function.
    During the live time...
Patient-prosthesis mismatch: surgical and transcatheter approaches

TAVI is a mature procedure: implications for lifelong management of young and old patients

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about TAVI implications for lifelong management, to understand what is happening in the field of aortic valve intervention and to appreciate the evidence governing the application of this procedure in the lifetime journey of patients with aortic...

TAVI is a mature procedure: implications for lifelong management of young and old patients